Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06852950 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
A NA study of Hyperglycemia and Type 2 Diabetes Mellitus (T2DM), sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06852950 is a NA study of Hyperglycemia and Type 2 Diabetes Mellitus (T2DM) that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 60 participants, below the 877-participant average among 38 other Hyperglycemia trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06852950, a NA study of Hyperglycemia and Type 2 Diabetes Mellitus (T2DM), is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfaction regarding diabetes care, particularly in the matter of blood glucose monitoring, at the transitions of care from the inpatient setting to the ambulatory setting.
Conditions Studied
Interventions
- DEVICE Libre 3 Plus Continuous Glucose Monitor
- DEVICE Dexcom G7 Continuous Glucose Monitor
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-03-09 |
| Est. Completion | 2027-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06852950
The ClinicalTrials.gov registry entry for NCT06852950 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 877-participant average among 38 other Hyperglycemia trials with a reported enrollment target (93% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Hyperglycemia appearing as the primary indexed condition, and to 2 interventions - of which Libre 3 Plus Continuous Glucose Monitor is the first listed.
NCT06852950 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT06852950 about?
NCT06852950 is a clinical study titled "Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge". This study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfaction regarding diabetes care, particularly in the matter of blood glucose monitoring, at the transitions of care from the inpatient setting ...
What is the current status of trial NCT06852950?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-03-09. Estimated completion is 2027-01.
What conditions does trial NCT06852950 study?
This clinical trial studies the following conditions: Hyperglycemia, Type 2 Diabetes Mellitus (T2DM), Type 1 Diabetes Mellitus (T1DM).
What interventions are being tested in trial NCT06852950?
The interventions under investigation include: Libre 3 Plus Continuous Glucose Monitor (DEVICE), Dexcom G7 Continuous Glucose Monitor (DEVICE).
Who is sponsoring clinical trial NCT06852950?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06852950 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperglycemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
-
Time to Move in Pregnancy Hyperglycemia
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.